Caoimhghín Ó Caoláin (Cavan-Monaghan, Sinn Fein)
Link to this: Individually | In context

Question 872: To ask the Minister for Health and Children the situation regarding achieving the targets outlined in the National Cancer Strategy; if any of the targets have been met within the timeframe set; if so, if she will outline same; and if not, when these targets will be achieved. [2413/07]

Mary Harney (Dublin Mid West, Progressive Democrats)
Link to this: Individually | In context

The aim of the National Cancer Control Strategy, which was published in June 2006, is to reduce our cancer incidence, morbidity and mortality rates relative to other Member States of the European Union. The Strategy encompasses all aspects of cancer control, including prevention, screening, diagnosis, treatment, supportive and palliative care. This Government is committed to investing significantly in the implementation of the Strategy. I have made available an additional €20.5m this year for cancer control. This is an increase of 74% on the comparable 2006 investment.

The Health Service Executive (HSE) is establishing a National Cancer Control Programme to manage, organise and deliver cancer control on a whole population basis. The Programme will have a strong emphasis on prevention and early detection, integrated across primary, hospital, supportive and palliative care.

Evidence based population based screening programmes are an essential element of the Strategy. I established a National Cancer Screening Service Board on 1 January this year. It takes over responsibility for BreastCheck and the Irish Cervical Screening Programme. The total allocation to the new Service is €33m, a 71% increase on the funding available in 2006. This includes €8m for the roll out of the national breast screening programme to the West and South which will commence this Spring and €5m to commence the roll out of a national cervical screening programme later this year. The Service will also advise on the implementation of a national colorectal screening programme, specifically on the population to be screened, at what intervals screening should take place, and the requirements for a quality assured and well organised cost effective symptomatic service.